Form 4 for ORIC Oric Pharmaceuticals, Inc.

Accepted 2022-03-25 00:00:00 ET · period of report 2022-03-23 · accession 0001209191-22-021153 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2022-03-25	2022-03-23+	ORIC	Chacko Jacob	Pres, CEO, Dir	P - Purchase	$4.92	+350.0K	259.8K	New	+$1.72M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-03-25	P	A	50,000	$4.54	352,652	D	—	—	(F3) Represents the weighted average share price of an aggregate total of 50,000 shares purchased in the price range of $4.455 to $4.60 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
2	Common	Common Stock	2022-03-24	P	A	42,873	$5.03	302,652	D	—	—	(F2) Represents the weighted average share price of an aggregate total of 42,873 shares purchased in the price range of $5.03 to $5.05 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
3	Common	Common Stock	2022-03-23	P	A	257,127	$4.98	259,779	D	—	—	(F1) Represents the weighted average share price of an aggregate total of 257,127 shares purchased in the price range of $4.73 to $5.10 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.